IHGP — Jun An Kang Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $45.53m
- $53.75m
- $4.47m
Annual income statement for Jun An Kang, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | 10KSB/A | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.041 | 2.19 | 3.2 | 4.47 |
Cost of Revenue | |||||
Gross Profit | — | — | 1.17 | 1.42 | 2.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.629 | 4.85 | 4.07 | 5.01 | 6.57 |
Operating Profit | -0.629 | -4.81 | -1.88 | -1.82 | -2.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.629 | -4.81 | -1.91 | -2.82 | -3.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.629 | -4.81 | -1.75 | -2.82 | -3.25 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.629 | -4.81 | -1.75 | -2.82 | -3.25 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.629 | -5.06 | -1.75 | -2.82 | -3.25 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -16,050,000 | -20,577 | -3,861 | -2,346,922 | -4.54 |
Dividends per Share |